Safety of adalimumab biosimilar MSB11022 (acetate-buffered formulation) in patients with moderately-to-severely active rheumatoid arthritis. [electronic resource]

By: Contributor(s): Producer: 20200406Description: 3381-3390 p. digitalISSN:
  • 1434-9949
Subject(s): Online resources: In: Clinical rheumatology vol. 38
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

There are no comments on this title.

to post a comment.